BenzingaAugust 11, 2026 at 7:14 AM NY24 days ago
RBC Capital Maintains Outperform on Biohaven, Raises Price Target to $23
RBC Capital analyst Leonid Timashev maintains Biohaven (NYSE:BHVN) with a Outperform and raises the price target from $22 to $23.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
Micron and Western Digital Shares Skyrocket, What You Need To Know
Yahoo2 hours ago
FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know
Yahoo2 hours ago
SpaceX is now in your 401(k), and Musk is the risk
Yahoo3 hours ago
Tesla (TSLA) Stock Trades Down, Here Is Why
Yahoo3 hours ago
Why Fair Isaac Corporation (FICO) Shares Are Getting Obliterated Today
Yahoo4 hours ago